Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 12 matching records
CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAINDepartment of Health and Human Services$1.6M obligationsEnds Jun 30, 2027
EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENTDepartment of Health and Human Services$1.9M obligationsEnds Jun 30, 2028
EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.Department of Health and Human Services$452.9K obligationsEnds May 31, 2026
THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMADepartment of Health and Human Services$680.2K obligationsEnds Apr 15, 2026
EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE…Department of Health and Human Services$2.3M obligationsEnds Jul 15, 2025
CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022Department of Health and Human Services$2.3M obligationsEnds Apr 28, 2025
EVALUATION OF POTENTIAL RESPIRATORY STIMULANT. TO4. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MARCH 20, 2025.Department of Health and Human Services$140.8K obligationsEnds Apr 28, 2025
RESPIRATORY INTERACTION STUDIES IN RODENTS, ABILITY OF A TEST ARTICLE TO REVERSE THE RESPIRATORY DEPRESSANT EFFECTS OF OPIOIDS. TO5. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MARCH…Department of Health and Human Services$211.1K obligationsEnds Apr 23, 2025
NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS. PERIOD OF PERFORMANCE SEPTEMBER 28, 2020 - DECEMBER 31, 2021Department of Health and Human Services$2.0M obligationsEnds Jul 31, 2025
BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGSDepartment of Health and Human Services$792.1K obligationsEnds Jun 30, 2025
CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021Department of Health and Human Services$1.3M obligationsEnds Dec 31, 2024
TASK ORDER ENTITLED, "PHARMACODYNAMICS OF THE MAS-RELATED GENE X2 (MRGX2) ANTAGONIST SYR268215 IN THE HUMANIZED MRGX2 KNOCK-IN (KI) MOUSE."Department of Health and Human Services$1.7K obligationsEnds Sep 17, 2022